Key facts
- This page summarizes Surendra K. Ajjarapu's Form 4/A filing for TRxADE HEALTH, INC (SCNX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 May 2024, 17:01.
Surendra K. Ajjarapu - 05 Jan 2024 Form 4/A Insider Report for TRxADE HEALTH, INC (SCNX)
- Reporting relationship
- Chairman and CEO, Director
- Issuer ticker
- SCNX
- Reported as of
- 05 Jan 2024
- Net transaction value
- $0
- SEC form
- 4/A
- Accepted by SEC
- 28 May 2024, 17:01:21 UTC
- Original report date
- 16 Jan 2024
- Prior SEC filing
- 28 Aug 2023
- Next SEC filing
- 20 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Surendra K. Ajjarapu
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Surendra K. Ajjarapu filed Form 4/A for TRxADE HEALTH, INC (SCNX) on 28 May 2024.
Change
- Previous filing in this sequence was filed on 28 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MEDS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +10,000
- Change %
- +14%
- Price
- $0.000000
- Shares after
- 82,643
- Date
- 05 Jan 2024
- Ownership
- Direct
- Footnotes
- F1, F2, F3
MEDS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,449
- Date
- 05 Jan 2024
- Ownership
- By Sandhya Ajjarapu (Spouse)
- Footnotes
- F4
MEDS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 34,844
- Date
- 05 Jan 2024
- Ownership
- By Surendra Ajjarapu Revocable Trust 2007
- Footnotes
- F5
MEDS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 89,167
- Date
- 05 Jan 2024
- Ownership
- By Sandhya Ajjarapu Revocable Trust 2007
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
This Form 4/A is being filed to amend the previous Form 4 filed by Mr. Ajjarapu on January 16, 2024 (the "Prior Form 4"). The purpose of this Form 4/A is to: (i) correct the number of securities acquired on or about January 5, 2024; (ii) correct the amount of securities beneficially owned by Mr. Ajjarapu as of that date; and (iii) correct Mr. Ajjarapu's form of ownership.
Footnote F2
The shares were granted as consideration for services rendered by Mr. Ajjarapu.
Footnote F3
These securities are owned directly by Mr. Ajjarapu.
Footnote F4
These securities are owned directly by Sandhya Ajjarapu, Mr. Ajjarapu's wife. By nature of their spousal relationship, Mr. Ajjarapu is deemed to be the indirect beneficial owner of the shares held by Mrs. Ajjarapu.
Footnote F5
These securities are owned directly by the Surendra Ajjarapu Revocable Trust 2007 (the "Surendra Trust"). Mr. Ajjarapu is the trustee of the Surendra Trust and, in such capacity, is deemed to be the indirect beneficial owner of the shares held by the Surendra Trust.
Footnote F6
These securities are owned directly by the Sandhya Ajjarapu Revocable Trust 2007 (the "Sandhya Trust"). Mrs. Ajjarapu is the trustee of the Sandhya Trust. Mrs. Ajjarapu's pecuniary interest in the Sandhya Trust is attributable to Mr. Ajjarapu by nature of their spousal relationship, so Mr. Ajjarapu is deemed to be the indirect beneficial owner of the shares held by the Sandhya Trust.